Bruker Corp (FRA:BKD)
€ 59.28 1.32 (2.28%) Market Cap: 8.99 Bil Enterprise Value: 10.02 Bil PE Ratio: 23.53 PB Ratio: 6.64 GF Score: 95/100

Bruker Corp at Jefferies Healthcare Conference (Virtual) Transcript

Jun 04, 2020 / 01:30PM GMT
Release Date Price: €39.4 (-0.51%)
Brandon Couillard
Jefferies LLC, Research Division - Equity Analyst

Hey, good morning. Welcome to the Jefferies 2020 Virtual Global Healthcare Conference. I'm Brandon Couillard, Senior Life Science Tools and Diagnostics Analyst here at the firm.

Here I'm happy to have Bruker with us back at the conference this year. From the company, we've got Chairman, CEO, Dr. Frank Laukien; as well as Juergen Srega, who heads Bruker's CALID unit.

I'll turn it over to frank to make a few opening remarks before jumping into Q&A. (Operator Instructions)

Frank, thanks for being here.

Frank H. Laukien
Bruker Corporation - Chairman, CEO & President

Thank you, Brandon. It's great to be at the Jefferies healthcare conference again and again with Juergen in ASMS week, although this year, of course, it's a virtual ASMS 2020 reboot, as they call it.

As you will have seen from our press release that we issued for -- with our product launches for ASMS, I think we have -- we can be very pleased with our R&D productivity and the new

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot